The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular…

After years of limited success, researchers have found a way to convert type A blood cells into the more universal type O by leveraging human gut bacteria, according to a report in the magazine Science.

Type O…

Canadian researchers have singled out a peptide known as apelin that could improve survival in CV patients with aortic aneurysms, leading them to dub the molecule the equivalent of insulin for heart disease.

Gavin…

A Wisconsin high schooler is speaking up for stroke awareness after she suffered a stroke of her own during gym class, WAOW reported—an event her doctors said was brought on by her birth control pills.

Like two-thirds…

Arizona-based R3 Stem Cell, LLC is under fire this week after the FDA sent the company an untitled, three-page letter detailing significant shortcomings in their process.

People who take popular heartburn drugs like Prevacid, Prilosec and Nexium are vulnerable to death from cardiovascular disease, chronic kidney disease (CKD) and upper gastrointestinal cancer, according to new research published in…

Smoking flavored e-cigarettes can have a detrimental effect on endothelial function, leaving e-cig users prone to poor vascular health and heart disease, researchers report in the June edition of the…

The popular anticoagulant dabigatran is no more effective than aspirin when it comes to preventing recurrent stroke in patients with a history of embolic events, researchers reported in the …

Researchers have linked a specific type of immune cell found in arterial plaque to increased probability of a stroke or mini-stroke.  

Chiara Giannarelli, MD, PhD, and colleagues’ study dissected and scrutinized human…

Fragmin (dalteparin sodium), a type of heparin that works as an anticoagulant, was approved by the FDA May 16 to treat symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and up.

The FDA…

A dietary supplement commonly used to relieve osteoarthritis and joint pain may also double as a cardioprotector, Tulane University researchers reported in The BMJ May 14…

A team funded by the National Institutes of Health has succeeded in growing human acellular vessels (HAVs)—implantable, bioengineered human blood vessels—to replace damaged vasculature in patients with end-stage kidney failure.

The migraine medication galcanezumab didn't result in clinically meaningful differences in blood pressure, pulse, ECG results or an increase in CV events compared with placebo in a study presented at the American Academy of Neurology’s…

Pennsylvania-based health company Orchestra BioMed has obtained FDA breakthrough device designation for its Virtue sirolimus-eluting balloon (SEB), according to a…

The FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet in mid-June to discuss recent controversies and safety practices surrounding paclitaxel-coated and -eluting medical devices, according to a…

The first study to test an experimental antiplatelet compound in humans found the therapy inhibited clot formation without increasing bleeding, suggesting it could avoid that dangerous side effect of other clot-preventing drugs. …

Three physicians published an editorial in Stroke proposing that tertiary healthcare centers in cities be held to stricter standards for performing…

When couples attended smoking cessation programs together, their odds of quitting were nearly six times higher than for people who attempted to kick the habit alone, according to…

Endovascular thrombectomy (EVT) significantly reduced the risk of 90-day mortality in patients with acute ischemic stroke compared to medical therapy alone, according to a…

Left atrial appendage (LAA) closure with the Watchman device was associated with low rates of stroke and bleeding events in high-risk atrial fibrillation patients over a two-year follow-up period, according to a real-world…

Compared to warfarin, all direct oral anticoagulants (DOACs) were associated with fewer cardiovascular events including heart attacks and strokes in a study…